SA
LH icon

Sycale Advisors’s Labcorp LH Stock Holding History

Sycale Advisors’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-42,449
Closed -$9.73M – 28
2024
Q4 		$9.73M Sell
42,449
-37,731
-47% -$8.66M 2.52% 17
2024
Q3 		$17.9M Sell
80,180
-13,020
-14% -$2.86M 3.36% 10
2024
Q2 		$19M Buy
93,200
+62,200
+201% +$12.7M 5.44% 7
2024
Q1 		$6.77M Buy
+31,000
New +$6.83M 1.89% 13
2020
Q3 		– Sell
-53,145
Closed -$7.58M – 17
2020
Q2 		$7.58M Buy
+53,145
New +$7.35M 5.8% 9

Other funds holding LH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sycale Advisors's LH Position: Q1 2025 in Review

Sycale Advisors sold out of Labcorp (LH) in Q1 2025, closing a stake of 42,449 shares — an estimated $9.73M sold.

Sycale Advisors first reported a position in LH in Q2 2020 and held it in 5 quarters. The position peaked at $19M in Q2 2024. 972 funds tracked by Wall St. Rank hold LH as of Q1 2025.

  • Sycale Advisors reported no remaining Labcorp position as of Q1 2025 after selling out during the quarter.
  • Sycale Advisors sold 42,449 Labcorp shares in Q1 2025, an estimated $9.73M.
  • Sycale Advisors first reported a position in Labcorp in Q2 2020 and held it in 5 quarters.
  • Sycale Advisors's Labcorp position peaked at $19M in Q2 2024.
  • 972 funds tracked by Wall St. Rank held Labcorp as of Q1 2025.

Based on Sycale Advisors's 13F filing for Q1 2025, filed 15 May 2025.